The FDA has proposed new guidance requiring stronger warnings and improved patient communication about LASIK risks. This represents a significant acknowledgment that prospective patients are not being adequately informed.

Key Points:

• Patients should receive a “decision checklist” describing risks
• Enhanced disclosure of potential complications required
• Recognition that current informed consent is inadequate

Read Full Article